In July 2007, EMEA announced that it had recommended to the Commission that all drugs containing the substance“veralipride”, including Agreal, be withdrawn from the European market.
I mí Iúil 2007, d’fhógair EMEA gur mhol sé don Choimisiún na drugaí ar fad a raibh an tsubstaint “veralipride” iontu, lena n-áirítear Agreal, a bhaint de mhargadh na hEorpa.